<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="other biocidal agents, such as 0.05–0.2% benzalkonium chloride, or 0.02%" exact="chlorhexidine" post="digluconate, are less effective [24]. The avoidance of these"/>
 <result pre="phytonutrients provide the antioxidants and the anti-inflammatory nutrients, including beta-carotene," exact="vitamin C," post="vitamin E, and polyphenolic compounds, which modulate the immune"/>
 <result pre="chronic disease comorbidity and age, in which lower concentrations of" exact="25(OH)D" post="have been reported. Vitamin D deficiency is globally prevalent,"/>
 <result pre="COVID-19, the goal should be to raise the concentrations of" exact="25(OH)D" post="above 40–60 ng/ml (100–150 nmol/l) by considering taking 10,000"/>
 <result pre="40–60 ng/ml (100–150 nmol/l) by considering taking 10,000 IU/d of" exact="vitamin D3" post="for a few weeks to rapidly raise 25(OH)D concentrations,"/>
 <result pre="of vitamin D3 for a few weeks to rapidly raise" exact="25(OH)D" post="concentrations, followed by 5000 IU/d. [67,75]. 4.2 Vitamin A"/>
 <result pre="early days [81,82]. The immune-modulating effects in respiratory infection of" exact="vitamin C" post="are also well-documented [[83], [84], [85], [86]]. Nevertheless, the"/>
 <result pre="well-documented [[83], [84], [85], [86]]. Nevertheless, the supporting evidence of" exact="vitamin C" post="supplementation in the prevention and treatment of acute respiratory"/>
 <result pre="the evidence of other micronutrients, the supplementation could benefit the" exact="vitamin C" post="deficient individual but not in the healthy subjects [87,88]."/>
 <result pre="symptoms [89,90]. Furthermore, five trials with 598 participants showed that" exact="vitamin C" post="decreased the risk of common cold without any adverse"/>
 <result pre="Selenium As the integral part of several selenoproteins, including the" exact="glutathione" post="peroxidases and thioredoxin reductases, selenium has a critical role"/>
 <result pre="blockages of the virus entry into the host cells 5.2.1" exact="Chloroquine" post="and hydroxychloroquine These viral entry blockages include chloroquine, hydroxychloroquine"/>
 <result pre="the virus entry into the host cells 5.2.1 Chloroquine and" exact="hydroxychloroquine" post="These viral entry blockages include chloroquine, hydroxychloroquine umifenovir, and"/>
 <result pre="5.2.1 Chloroquine and hydroxychloroquine These viral entry blockages include chloroquine," exact="hydroxychloroquine" post="umifenovir, and interferon [112]. A cell line study reported"/>
 <result pre="umifenovir, and interferon [112]. A cell line study reported that" exact="chloroquine" post="significantly decreased the human coronavirus-229E replication at a lower"/>
 <result pre="the clinical safety profiles, that justify future clinical research of" exact="chloroquine" post="and hydroxychloroquine in patients with COVID-19 [114]. There are"/>
 <result pre="safety profiles, that justify future clinical research of chloroquine and" exact="hydroxychloroquine" post="in patients with COVID-19 [114]. There are currently several"/>
 <result pre="with COVID-19 [114]. There are currently several clinical trials of" exact="chloroquine" post="for COVID-19, either as monotherapy or in combination with"/>
 <result pre="as monotherapy or in combination with other medications such as" exact="azithromycin" post="[112]. A non-randomized clinical trial reported the reduction of"/>
 <result pre="failed to report the critical clinical outcomes, including death [115]." exact="Chloroquine" post="and hydroxychloroquine are the immunomodulatory drugs with potential antiviral"/>
 <result pre="report the critical clinical outcomes, including death [115]. Chloroquine and" exact="hydroxychloroquine" post="are the immunomodulatory drugs with potential antiviral effects. However,"/>
 <result pre="medications. It is still premature to conclude the role of" exact="chloroquine" post="and hydroxychloroquine in COVID-19, while several clinical trials are"/>
 <result pre="is still premature to conclude the role of chloroquine and" exact="hydroxychloroquine" post="in COVID-19, while several clinical trials are on their"/>
 <result pre="There is a known TMPRRSS2 inhibitor in the market, i.e.," exact="camostat" post="mesylate. Machine learning algorithms have been used to predict"/>
 <result pre="pathway, including Janus-associated kinase (JAK) inhibitors through baricitinib, ruxolitinib, and" exact="imatinib" post="[119,120]. Currently, some of these drugs are being tested"/>
 <result pre="of HIV infection [137]. The cytochrome P450 inhibitory effects of" exact="ritonavir" post="prolonged the half-life of Lopinavir and extended its protease"/>
 <result pre="uses in combination with other cytochrome P450 inhibitors, such as" exact="ritonavir" post="or cobicistat, for the treatment of HIV infection [143]."/>
 <result pre="coronavirusJ. Antimicrob. Chemother.5220031049105010.1093/jac/dkh00214613951 87HemiläH.Vitamin C and infectionsNutrients9201733910.3390/nu9040339 88van DrielM.L.BellerE.M.ThielemansE.DeckxL.Price-HaywoodE.ClarkJ.De SutterA.I.M.Oral" exact="vitamin C" post="supplements to prevent and treat acute upper respiratory tract"/>
 <result pre="of vitamin CExpert Rev. Anti Infect. Ther.1820209910110.1080/14787210.2020.170648331852327 92GortonH.C.JarvisK.The effectiveness of" exact="vitamin C" post="in preventing and relieving the symptoms of virus-induced respiratory"/>
 <result pre="virus-induced respiratory infectionsJ. Manipulative Physiol. Ther.22199953053310543583 93MagginiS.BeveridgeS.SuterM.A combination of high-dose" exact="vitamin C" post="plus zinc for the common coldJ. Int. Med. Res.402012284222429343"/>
 <result pre="Res.77200815015218055026 114CortegianiA.IngogliaG.IppolitoM.GiarratanoA.EinavS.A systematic review on the efficacy and safety of" exact="chloroquine" post="for the treatment of COVID-19J. Crit. Care202010.1016/j.jcrc.2020.03.005(Epub ahead of"/>
 <result pre="treatment of COVID-19J. Crit. Care202010.1016/j.jcrc.2020.03.005(Epub ahead of print) 115GautretP.LagierJ.-C.ParolaP.HoangV.T.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraV.DupontH.HonoréS.ColsonP.ScolaB.RolainJ.-M.BrouquiP.RaoultD.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
 <result pre="treatment of hemorrhagic fever virus infectionsChem. Asian J.1420193962396831389664 133WangM.CaoR.ZhangL.YangX.LiuJ.XuM.ShiZ.HuZ.ZhongW.XiaoG.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="SARS: initial virological and clinical findingsThorax59200425225610.1136/thorax.2003.01265814985565 141KimU.J.WonE.-J.KeeS.-J.JungS.-I.JangH.-C.Combination therapy with lopinavir/ritonavir," exact="ribavirin" post="and interferon-α for Middle East respiratory syndromeAntivir. Ther.21201645545910.3851/IMP300226492219 142ArabiY.M.AsiriA.Y.AssiriA.M.JokhdarH.A."/>
</results>
